DUX4 and facioscapulohumeral muscular dystrophy: The unusual FSHD disease mechanism, the epigenetic reactivation of the DUX4 gene, is particularly amenable to knock-down of DUX4 using epigenetic strategies or RNA therapies, as well as to other interventions targeting the downstream effects of DUX4 expression.